Acclinate Collaborates with Merck to Increase Clinical Trial Diversity

Acclinate to provide community engagement support for Merck’s oncology clinical trials. [Birmingham, AL, November 30th, 2023] – Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the

Read More

Acclinate Unveils Elevated NOWINCLUDED.COM to Empower Black Health and Wellness Nationwide

[Birmingham, AL — November 6, 2023] — Acclinate proudly announces the relaunch of NOWINCLUDED.COM, a groundbreaking digital platform dedicated to amplifying Black voices in health and creating safe, inclusive spaces both online and in communities

Read More

AI (Software & Service Providers) in the Global Clinical Trials Market, 2023-2035: Oncological Disorders Likely to Be the Primary Target Therapeutic Area

August 21, 2023 07:52 AM Eastern Daylight Time [DUBLIN–(BUSINESS WIRE)]The “AI (Software & Service Providers) in the Clinical Trials Market, 2023-2035” r “AI (Software & Service Providers) in the Clinical Trials Market, 2023-2035” The global AI in

Read More

Acclinate Partners with Alabama Regional Medical Services to Promote Health Equity and Increase Diversity in Clinical Research

[BIRMINGHAM, August 8, 2023] – Acclinate, a leading digital health startup specializing in health equity through inclusive research, is proud to announce a strategic partnership with Alabama Regional Medical Services (ARMS), a federally qualified health

Read More

Trialbee and Acclinate Partner to Enhance Equitable Clinical Trial Participation

[CHAPEL HILL, N.C. & BIRMINGHAM, Ala.–(BUSINESS WIRE)] Trialbee, the leader in data and technology-based patient recruitment and enrollment for clinical trials, today announced a partnership with Acclinate, whose NOWINCLUDED™ community accesses and engages diverse populations on

Read More

Johnson & Johnson Innovation Names Awardees of the Maternal-fetal Immune Disorders QuickFire Challenge: Innovating for Health Equity

Johnson & Johnson Innovation in collaboration with the Office of the Chief Medical Officer of The Johnson & Johnson Family of Companies (OCMO) Health of Women team, together with The Janssen Pharmaceutical Companies of Johnson &

Read More

Lightship® and Acclinate Announce Partnership to Increase Access to Clinical Trials for Diverse Populations

Lightship, a clinical research solutions provider and Acclinate, a digital health company, are collaborating to increase access and engagement of diverse participants in a decentralized neurology clinical trial for a large pharmaceutical company. [NEW YORK and EL SEGUNDO,

Read More

Acclinate Wins DPHARM Idol Disrupt 2022 Presented at 12th Annual DPHARM from the Conference Forum

[BOSTON, Sept. 14, 2022  /PRNewswire-PRWeb/] The Conference Forum is pleased to announce that Acclinate is the winner of DPHARM Idol Disrupt at the 12th annual DPHARM: Disruptive Innovations to Modernize Clinical Research 2022 event. Acclinate, represented by Del

Read More